Apeximmune
Pre-clinicalApeximmune Therapeutics is pioneering a new generation of therapeutic antibodies that harness the power of the immune system to treat cancers.Apeximmune’s mission is to harness the power of the immune system to treat cancer and autoimmune disease.
Founded
2020
Focus
AntibodiesBiologics
About
Apeximmune Therapeutics is pioneering a new generation of therapeutic antibodies that harness the power of the immune system to treat cancers.Apeximmune’s mission is to harness the power of the immune system to treat cancer and autoimmune disease.
Funding History
2Total raised: $30M
Series A$25MUndisclosedNov 15, 2023
Seed$5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2020
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile